Skip to main content Help with accessibility Skip to main navigation

Degarelix

Indication

treatment of adult male patients with advanced hormonedependent prostate cancer - patients without spinal metastases

Grey

Brand:

Nice TA:

Commissioning responsibility:

PbR excluded:

No

BNF chapter:
Immune system and Malignant Disease

Background

Recommendation

LSCMMG Recommendation:

Grey

Reason for decision:

Prioritised for review

Supporting documents:

Decisions of Lancashire local decision making groups

Pending
Pending
Pending
Pending
Pending
Pending
Pending
Pending
What do the colours mean?

Last Updated: 13 - May - 2022